Prescription drug · ANDA
Methylergonovine Maleate (Methylergonovine) NDC 69238-1605
Methylergonovine maleate .2 mg/1 · Tablet · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69238-1605-2 | 69238160502 | 12 TABLET in 1 BOTTLE (69238-1605-2)Marketed from Sep 12, 2018 | |
| 69238-1605-8 | 69238160508 | 28 TABLET in 1 BOTTLE (69238-1605-8)Marketed from Sep 12, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylergonovine Maleate
- Generic name (nonproprietary)
- methylergonovine
- Active ingredients
- Methylergonovine maleate — .2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals NY LLCNDC labeler code 69238
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211483
- Marketing start
- Listing expires
- Other FDA classes
- Ergolines (Chemical structure)
- Identifiers
- Product ID 69238-1605_5c53f000-01eb-4042-bdb8-e569609413bfSPL ID 5c53f000-01eb-4042-bdb8-e569609413bfSPL set ID a7ec8dfe-9b58-4363-a709-c1b72ee67855RxCUI 996824UNII IR84JPZ1RK
- Pharmacologic class
- Ergot Derivative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469238160502followed by a unit qualifier and the quantityPackage 69238-1605-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder.
Excerpt only. Read the full label for complete information.
About NDC 69238-1605
- What is NDC 69238-1605?
- 69238-1605 is the product NDC for Methylergonovine Maleate (methylergonovine), Methylergonovine maleate .2 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methylergonovine Maleate (Methylergonovine).
- What is the active ingredient?
- Methylergonovine maleate.
- Who is the labeler?
- Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methylergonovine Maleate?
- 13 other product NDCs are listed under this name. See all Methylergonovine Maleate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methylergonovine Maleate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7282 | 00904-7282-10 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | American Health Packaging | 60687-813 | 60687-0813-94 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Volley Pharmaceuticals, LLC | 83400-100 | 83400-0100-1283400-0100-28 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1556 | 51662-1556-02 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-735 | 16571-0735-0116571-0735-1716571-0735-21+1 more |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-3655 | 00093-3655-2200093-3655-28 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Granules Pharmaceuticals Inc. | 70010-786 | 70010-0786-1270010-0786-28 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | Breckenridge Pharmaceutical, Inc. | 51991-144 | 51991-0144-17 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | Bryant Ranch Prepack | 63629-2074 | 63629-2074-01 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | Bryant Ranch Prepack | 72162-1592 | 72162-1592-02 |